Portola Pharmaceuticals, Inc.: Dr. John Curnutte, M.D., Ph.D., executive vice president and head of R&D, will retire on May 17, 2019, after more than eight years of service.
Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of Lilly Oncology Sue Mahony is set to retire from her role, effective 31 August.